Arthralgia News and Research

RSS
Arthralgia is a symptom of injury, infection, illnesses - in particular arthritis - or an allergic reaction to medication. According to MeSH, the term "arthralgia" should only be used when the condition is non-inflammatory, and the term "arthritis" should be used when the condition is inflammatory.
Tart cherry reduces joint pain and sore muscles in some breast cancer patients, study shows

Tart cherry reduces joint pain and sore muscles in some breast cancer patients, study shows

Scientific evidence for and against causal associations for 47 adverse effects after immunization

Scientific evidence for and against causal associations for 47 adverse effects after immunization

Immune checkpoint inhibitors induce rheumatic and musculoskeletal diseases

Immune checkpoint inhibitors induce rheumatic and musculoskeletal diseases

FDA approves generic drug for treating focal seizures

FDA approves generic drug for treating focal seizures

Nexus announces availability of Arsenic Trioxide Injection in the US

Nexus announces availability of Arsenic Trioxide Injection in the US

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Studies provide insight into molecular changes prior to onset of arthritis

Studies provide insight into molecular changes prior to onset of arthritis

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients